Nordea Investment Management
CRL icon

Nordea Investment Management’s Charles River Laboratories CRL Stock Holding History

Nordea Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5M Buy
68,482
+12,360
+22% +$2.2M 0.01% 395
2026
Q1 		$9.23M Buy
56,122
+1,428
+3% +$265K 0.01% 457
2025
Q4 		$11M Buy
54,694
+16,616
+44% +$3.01M 0.01% 430
2025
Q3 		$5.64M Buy
+38,078
New +$6.05M ﹤0.01% 567
2025
Q1 		– Sell
-4,761
Closed -$879K – 885
2024
Q4 		$879K Hold
4,761
– – ﹤0.01% 824
2024
Q3 		$939K Buy
4,761
+19
+0.4% +$3.95K ﹤0.01% 810
2024
Q2 		$992K Buy
4,742
+361
+8% +$81.8K ﹤0.01% 810
2024
Q1 		$1.19M Hold
4,381
– – ﹤0.01% 797
2023
Q4 		$1.04M Buy
4,381
+253
+6% +$49.8K ﹤0.01% 822
2023
Q3 		$817K Sell
4,128
-223
-5% -$45.8K ﹤0.01% 850
2023
Q2 		$922K Hold
4,351
– – ﹤0.01% 829
2023
Q1 		$869K Buy
4,351
+445
+11% +$101K ﹤0.01% 819
2022
Q4 		$850K Buy
3,906
+693
+22% +$151K ﹤0.01% 802
2022
Q3 		$638K Hold
3,213
– – ﹤0.01% 858
2022
Q2 		$689K Buy
3,213
+419
+15% +$102K ﹤0.01% 861
2022
Q1 		$806K Hold
2,794
– – ﹤0.01% 834
2021
Q4 		$1.05M Hold
2,794
– – ﹤0.01% 803
2021
Q3 		$1.2M Hold
2,794
– – ﹤0.01% 774
2021
Q2 		$1.03M Sell
2,794
-35,309
-93% -$11.8M ﹤0.01% 791
2021
Q1 		$11.1M Buy
38,103
+1,409
+4% +$392K 0.02% 361
2020
Q4 		$9.17M Sell
36,694
-860
-2% -$205K 0.01% 377
2020
Q3 		$8.39M Sell
37,554
-37,126
-50% -$7.7M 0.02% 355
2020
Q2 		$12.7M Buy
74,680
+36,991
+98% +$5.9M 0.01% 381
2020
Q1 		$4.85M Buy
37,689
+1,837
+5% +$276K 0.01% 424
2019
Q4 		$5.48M Buy
35,852
+673
+2% +$93.2K 0.01% 459
2019
Q3 		$4.68M Buy
35,179
+69
+0.2% +$9.25K 0.01% 519
2019
Q2 		$4.98M Sell
35,110
-31,074
-47% -$4.21M 0.01% 475
2019
Q1 		$9.61M Sell
66,184
-4,047
-6% -$532K 0.02% 392
2018
Q4 		$7.95M Sell
70,231
-4,410
-6% -$552K 0.02% 409
2018
Q3 		$10M Sell
74,641
-9,917
-12% -$1.22M 0.02% 401
2018
Q2 		$9.49M Buy
84,558
+230
+0.3% +$24.9K 0.02% 336
2018
Q1 		$9M Buy
84,328
+522
+0.6% +$56.3K 0.02% 330
2017
Q4 		$9.17M Sell
83,806
-85,948
-51% -$9.35M 0.02% 314
2017
Q3 		$18.3M Buy
169,754
+90,784
+115% +$9.33M 0.04% 223
2017
Q2 		$7.99M Buy
78,970
+1,878
+2% +$173K 0.02% 309
2017
Q1 		$6.93M Buy
77,092
+13,731
+22% +$1.17M 0.02% 318
2016
Q4 		$4.83M Buy
63,361
+22,676
+56% +$1.72M 0.01% 364
2016
Q3 		$3.39M Buy
40,685
+6,988
+21% +$586K 0.01% 387
2016
Q2 		$2.78M Buy
33,697
+5,506
+20% +$454K 0.01% 357
2016
Q1 		$2.14M Buy
28,191
+800
+3% +$59.2K 0.01% 394
2015
Q4 		$2.2M Sell
27,391
-200
-0.7% -$14.4K 0.01% 372
2015
Q3 		$1.75M Buy
27,591
+1,600
+6% +$115K 0.01% 344
2015
Q2 		$1.83M Buy
25,991
+2,811
+12% +$208K 0.01% 346
2015
Q1 		$1.84M Buy
23,180
+305
+1% +$22.5K 0.01% 352
2014
Q4 		$1.46M Sell
22,875
-8,200
-26% -$514K 0.01% 423
2014
Q3 		$1.86M Buy
31,075
+435
+1% +$24.9K 0.01% 383
2014
Q2 		$1.64M Buy
30,640
+1,610
+6% +$88.3K 0.01% 469
2014
Q1 		$1.75M Sell
29,030
-10,045
-26% -$586K 0.01% 447
2013
Q4 		$2.07M Buy
39,075
+3,165
+9% +$159K 0.01% 424
2013
Q3 		$1.66M Buy
35,910
+8,305
+30% +$381K 0.01% 475
2013
Q2 		$1.13M Buy
+27,605
New +$1.18M 0.01% 552

Other funds holding CRL

CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Nordea Investment Management's CRL Position: Q2 2026 in Review

Nordea Investment Management increased its Charles River Laboratories (CRL) stake by 22% in Q2 2026, buying an estimated $2.2M and bringing the position to 68,482 shares worth $15.5M. The position accounts for 0.01% of the portfolio, ranked #395.

Nordea Investment Management first reported a position in CRL in Q2 2013 and has held it in 51 quarters since. The position peaked at $18.3M in Q3 2017. 235 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Nordea Investment Management held 68,482 shares of Charles River Laboratories worth $15.5M as of Q2 2026.
  • Nordea Investment Management bought 12,360 Charles River Laboratories shares in Q2 2026, an estimated $2.2M.
  • Charles River Laboratories made up 0.01% of Nordea Investment Management's portfolio in Q2 2026, its #395 holding.
  • Nordea Investment Management first reported a position in Charles River Laboratories in Q2 2013 and has held it in 51 quarters since.
  • Nordea Investment Management's Charles River Laboratories position peaked at $18.3M in Q3 2017.
  • 235 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.